Dalantercept Uses, Dosage, Side Effects and more
Dalantercept is under investigation in clinical trial NCT00996957 (Study of ACE-041 in Patients With Advanced Solid Tumors or Relapsed/Refractory Multiple Myeloma).
| Trade Name | Dalantercept |
| Generic | Dalantercept |
| Dalantercept Other Names | Dalantercept |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
